Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



TANG KEVIN C Create: Alert

All | News | Filings
Date FiledTypeDescription
10/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/14/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
06/01/2023 4 TANG KEVIN C (10% Owner) has filed a Form 4 on Rain Oncology Inc.
Txns: Bought 347,932 shares @ $1.05, valued at $365.3k
Bought 200,000 shares @ $1, valued at $200k
Bought 32,890 shares @ $1.06, valued at $34.9k
Bought 2,016 shares @ $1.08, valued at $2.2k
Bought 5,930 shares @ $1.06, valued at $6.3k
Bought 161,180 shares @ $1.08, valued at $174.1k
Bought 5,000 shares @ $1.1, valued at $5.5k
Bought 92,984 shares @ $1.09, valued at $101.4k
Bought 240,341 shares @ $1.12, valued at $269.2k
06/01/2023 3 TANG KEVIN C (10% Owner) has filed a Form 3 on Rain Oncology Inc.
05/30/2023 4 TANG KEVIN C (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Bought 50,000 shares @ $1.72, valued at $86k
05/15/2023 4 TANG KEVIN C (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Bought 38,765 shares @ $1.95, valued at $75.6k
Bought 6,183 shares @ $1.95, valued at $12.1k
05/10/2023 4 TANG KEVIN C (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Bought 57,073 shares @ $1.95, valued at $111.3k
Bought 20,141 shares @ $1.95, valued at $39.3k
Bought 6,774 shares @ $1.95, valued at $13.2k
05/05/2023 4 TANG KEVIN C (10% Owner) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Bought 18,513 shares @ $1.85, valued at $34.2k
Bought 104,241 shares @ $1.86, valued at $193.9k
Bought 95,759 shares @ $1.9, valued at $181.9k
Bought 71,064 shares @ $1.94, valued at $137.9k
05/05/2023 3 TANG KEVIN C (10% Owner) has filed a Form 3 on TCR2 THERAPEUTICS INC.
05/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/14/2023 4 TANG KEVIN C (10% Owner) has filed a Form 4 on Jounce Therapeutics, Inc.
Txns: Bought 65,701 shares @ $0.994, valued at $65.3k
Bought 20,286 shares @ $1.018, valued at $20.7k
03/14/2023 3 TANG KEVIN C (10% Owner) has filed a Form 3 on Jounce Therapeutics, Inc.
02/14/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
11/14/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/24/2022 4 TANG KEVIN C (10% Owner) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Unknown transaction of 9,607,934 shares @ $6.23, valued at $59.9M
Disposed/sold 18,000 options to buy @ $9.2, valued at $165.6k
Disposed/sold 10,000 options to buy @ $19.69, valued at $196.9k
Disposed/sold 10,000 options to buy @ $28.24, valued at $282.4k
Disposed/sold 10,000 options to buy @ $19.19, valued at $191.9k
Disposed/sold 10,000 options to buy @ $28.1, valued at $281k
Disposed/sold 12,000 options to buy @ $5.99, valued at $71.9k
Disposed/sold 12,000 options to buy @ $3.93, valued at $47.2k
Disposed/sold 30,000 options to buy @ $4.53, valued at $135.9k
Disposed/sold 30,000 options to buy @ $4.81, valued at $144.3k
Unknown transaction of 3,519 options to buy @ $0
08/24/2022 4 TANG KEVIN C (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Unknown transaction of 9,607,934 shares @ $6.23, valued at $59.9M
Unknown transaction of 3,519 options to buy @ $0
08/15/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/16/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/14/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
01/14/2022 4 TANG KEVIN C (10% Owner) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Granted 30,000 options to buy @ $4.81, valued at $144.3k
12/01/2021 4 TANG KEVIN C (CFO) has filed a Form 4 on LA JOLLA PHARMACEUTICAL CO
Txns: Sold 193,403 shares @ $4.1008, valued at $793.1k
Sold 6,597 shares @ $3.9514, valued at $26.1k
Sold 63,745 shares @ $3.9461, valued at $251.5k
Sold 136,255 shares @ $3.7586, valued at $512.1k
Sold 41,290 shares @ $3.6644, valued at $151.3k
11/26/2021 4 TANG KEVIN C (Exit Filing) has filed a Form 4 on Aptevo Therapeutics Inc.
Txns: Sold 161,336 shares @ $13.5216, valued at $2.2M
Sold 124,509 shares @ $12.4504, valued at $1.6M
Sold 75,491 shares @ $11.7422, valued at $886.4k
Sold 149,111 shares @ $11.1892, valued at $1.7M
Sold 50,889 shares @ $10.4279, valued at $530.7k
Sold 200,000 shares @ $10.0722, valued at $2M
Sold 160,000 shares @ $9.6035, valued at $1.5M
11/22/2021 4 TANG KEVIN C (10% Owner) has filed a Form 4 on Aptevo Therapeutics Inc.
Txns: Sold 43,213 shares @ $9.3845, valued at $405.5k
Sold 152,764 shares @ $8.3234, valued at $1.3M
Sold 4,023 shares @ $8.0015, valued at $32.2k
Sold 169,533 shares @ $8.0947, valued at $1.4M
Sold 30,467 shares @ $8.0123, valued at $244.1k
Sold 183,333 shares @ $7.5205, valued at $1.4M
Sold 16,667 shares @ $7.3589, valued at $122.7k
Sold 196,281 shares @ $7.1081, valued at $1.4M
Sold 3,719 shares @ $6.6627, valued at $24.8k
Sold 38,664 shares @ $6.5532, valued at $253.4k
11/19/2021 4 TANG KEVIN C (CEO) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Sold 468,849 shares @ $2.6583, valued at $1.2M
Sold 31,151 shares @ $1.9941, valued at $62.1k
Sold 500,000 shares @ $2.0161, valued at $1M
Sold 287,577 shares @ $2.1985, valued at $632.2k
Sold 212,423 shares @ $1.9708, valued at $418.6k
Sold 500,000 shares @ $1.8812, valued at $940.6k
Sold 381,842 shares @ $1.8925, valued at $722.6k
Sold 365,289 shares @ $1.9161, valued at $699.9k
11/15/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/16/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
06/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/17/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/04/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/16/2021 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
02/16/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
12/23/2020 4 TANG KEVIN C (CEO) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns: Bought 62,144 shares @ $14.5753, valued at $905.8k
Bought 37,856 shares @ $14.5754, valued at $551.8k
Bought 36,646 shares @ $15.1673, valued at $555.8k
Bought 63,354 shares @ $15.4282, valued at $977.4k
Bought 75,784 shares @ $15.708, valued at $1.2M
11/16/2020 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy